COMMUNIQUÉS West-GlobeNewswire

XBiotech Announces Upcoming Phase 2 Clinical Studies in Dermatology
16/04/2018
XBiotech to Launch Two Phase 2 Clinical Studies to Study Subcutaneous Administration of MABp1 for Treatment of Hidradenitis Suppurativa and Atopic Dermatitis AUSTIN, Texas, April 16, 2018 (GLOBE NEWSWIRE) -- XBiotech [...]
Extendicare Announces April 2018 Dividend of C$0.04 per Share
16/04/2018
MARKHAM, Ontario, April 16, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]
Advanced Proteome Therapeutics Announces CEO and Director Resignations
16/04/2018
VANCOUVER, British Columbia, April 16, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“ APC ” or the “ Company ”) (TSX-V: APC ) (FSE:0E8) announces that its Board of Directors has accepted the [...]
Emblem Continues to Bolster Professional Leadership Team with Three Strategic Hires to Grow Market Share
16/04/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, April 16, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) (“Emblem” or the “Company”) , a leading [...]
Tabula Rasa HealthCare Subsidiary CareKinesis is Exclusive Provider of In-Home Medication Reminder Device for PACE Organizations
16/04/2018
MOORESTOWN, N.J., April 16, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC ), a healthcare technology company that develops and employs medication risk mitigation software solutions and tools [...]
eFFECTOR Presents Data on the Discovery and Structure of eFT226, a Novel Inhibitor of eIF4A, at the AACR 2018 Annual Meeting
16/04/2018
eFFECTOR will also Present Two Posters Validating the Immunological Profile of eFT508 SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation [...]
Easton Pharmaceuticals Announces BAYER Agreement Update
16/04/2018
TORONTO, ON, April 16, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals Inc. (OTC: EAPH ) Announces update to its signed agreement with BAYER’s subsidiary company, Bayer Consumer Care. As previously announced, Easton [...]
Sun BioPharma, Inc. Announces Appointment of Susan Horvath as Vice President of Finance and Chief Financial Officer
16/04/2018
MINNEAPOLIS, April 16, 2018 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (OTCQB: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of pancreatic diseases, today announced [...]
Nephros Announces Preliminary Financial Results for First Quarter 2018
16/04/2018
Anticipates 39% Year-over-Year Product Revenue Growth; Reiterates $6 million 2018 Revenue Target SOUTH ORANGE, NJ, April 16, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device [...]
Terveystalo Plc: Terveystalo sells the entire share capital of Porin Linnankulma Mutual Real Estate Company
16/04/2018
Terveystalo Plc Stock Exchange Release 16 April 2018 at 14.30 EET Suomen Terveystalo Oy has entered into an agreement with the eQ Hoivakiinteistö Mutual Fund on 16 April 2018, with which Terveystalo sells the entire [...]
Aptose Presents New Preclinical Data on CG’806 Pan-FLT3/ Pan-BTK Inhibitor at 2018 AACR Annual Meeting
16/04/2018
CG’806 targets multiple pathways and kills cancer cells resistant to other FLT3 and BTK inhibitors CHICAGO and SAN DIEGO and TORONTO, April 16, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO ) (TSX: APS [...]
Veritas Pharma Enters Into Share Purchase Agreement with 3 Carbon Extractions Inc.
16/04/2018
3 Carbon is in the business of designing cannabis extraction facilities and utilizing its own proprietary extraction methods. VANCOUVER, British Columbia, April 16, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT [...]
OHSU and Aptose Present New CG’806 Preclinical Data at 2018 AACR Annual Meeting
16/04/2018
CG’806 Continues to Demonstrate Superior Activity to Other FLT3 and BTK Inhibitors Against Patient Samples CHICAGO and PORTLAND, Ore. and SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- Oregon Health & Science [...]
Cancer Genetics’ Unique Tissue of Origin Test (TOO®) Receives Special FDA 510(k) Clearance
16/04/2018
RUTHERFORD, N.J., April 16, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX ), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced that it has [...]
Detroit Tigers seventh annual Pink Out the Park Sunday, May 13, brings Fans and Community Together to Raise Awareness of Breast Health
16/04/2018
Celebrate Mother’s Day by paying tribute to moms and honoring breast cancer survivors. DETROIT, April 16, 2018 (GLOBE NEWSWIRE) -- The Detroit Tigers will present the seventh annual Pink Out the Park on Mother’s Day, [...]
ObsEva SA to Host Key Opinion Leader Meeting on In Vitro Fertilization (IVF) April 26, 2018 in New York City
16/04/2018
Geneva, Switzerland and Boston, MA - April 16, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]
Stemline Therapeutics Expands Board of Directors; Further Enhances Commercial Expertise with Appointment of Darren Cline
16/04/2018
NEW YORK, April 16, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, today announced expansion of its Board of [...]
Recro Pharma to Present IV Meloxicam Data at the 43rd Annual Regional Anesthesiology and Acute Pain Medicine Meeting
16/04/2018
MALVERN, Pa., April 16, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today [...]
Celldex’s METRIC Study in Metastatic Triple-negative Breast Cancer Does Not Meet Primary Endpoint
16/04/2018
Conference Call Scheduled for 8:00 a.m. ET Today HAMPTON, N.J., April 16, 2018 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ: CLDX ) today reported that the Company’s randomized, Phase 2b METRIC Study of [...]

Pages